It is worth noting that it is now widely accepted that pyruvate dehydrogenase kinase 3 (PDK3) and histone deacetylase 6 (HDAC6) inhibitors can be used to treat lung cancer [16,17]. Here, HDAC6 is linked to lung cancer.